Company
AIxMed
AI-Driven Digital Cytology: Cancer Cells Have Nowhere to Hide
- Business model
- B2B
- Customers
- Pathologists, Providers, Patients, Payors
- Legal name
- AIxMed, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Quantitative and qualitative data from our AI-powered computational platform enhances cytology insights to improve workflows and quality of patient care in the battle against cancer.
Funding snapshot
- Total raised
- $8.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $500K2022-04-01
Funding rounds
- Round, 2022
- $500K2022-04-01, SEC form D sold, 1 investor
- Round, 2021
- $7.8M2021-08-31, SEC form D sold, 29 investors
Products
- Web
- AIxURO
Loading relationship preview